Funding for this research was provided by:
National Health and Medical Research Council (1173871, 1145033, 1102792)
First Online: 16 March 2020
: S.R.L.’s institution received funding for investigator-initiated grants from Gilead Sciences, Merck, Viiv Healthcare and Leidos; and honoraria for advisory boards and educational activities (Gilead Sciences, Merck, Viiv Healthcare and Abbvie).
Free to read: This content has been made available to all.